Surveillance of laboratory exposures to human pathogens and toxins: Canada 2018.

Centre for Biosecurity Laboratory Incident Notification Canada human pathogens and toxins laboratory exposures laboratory incidents laboratory-acquired infections surveillance

Journal

Canada communicable disease report = Releve des maladies transmissibles au Canada
ISSN: 1188-4169
Titre abrégé: Can Commun Dis Rep
Pays: Canada
ID NLM: 9303729

Informations de publication

Date de publication:
05 Sep 2019
Historique:
entrez: 26 10 2019
pubmed: 28 10 2019
medline: 28 10 2019
Statut: epublish

Résumé

The Laboratory Incident Notification Canada (LINC) surveillance system monitors laboratory incidents reported under the To describe the laboratory exposure and laboratory-acquired infection incidents that occurred in Canada in 2018 compared to previous years, and then by sector, human pathogens and toxins involved, number of affected persons, incident type and root causes. Laboratory incidents that occurred in 2018 were reported through the LINC system. The number of laboratory incidents, people exposed and laboratory-acquired infections were compared to previous years, then the incidents were analyzed by sector, human pathogen or toxin involved, the type of incident, people exposed, route of exposure and root causes. Microsoft Excel 2016 was used for descriptive analysis. In 2018, there were 89 exposure incidents to human pathogens and 235 people were exposed. There were five suspected and one confirmed laboratory-acquired infections. This was approximately twice the number of exposure incidents that were reported in 2017 (n=44) and 2016 (n=46). The highest number of exposure incidents occurred in the academic and hospital sectors, and the ratio of incidence to licences was the lowest in the private sector. The majority of incidents (n=50; 56%) involved Risk Group 2 human pathogens that were manipulated in a Containment Level 2 laboratory. Most exposures were related to sharps or procedures and the most common people exposed were laboratory technicians. Human interaction and standard operating procedures were the leading root causes. Although overall the annual incidence of laboratory exposures in Canada remains relatively low, the incidence was higher in 2018 than in previous years. Whether this is a true increase in incidence or an increase in reporting is not known at this time as baseline estimates are still being established.

Sections du résumé

BACKGROUND BACKGROUND
The Laboratory Incident Notification Canada (LINC) surveillance system monitors laboratory incidents reported under the
OBJECTIVE OBJECTIVE
To describe the laboratory exposure and laboratory-acquired infection incidents that occurred in Canada in 2018 compared to previous years, and then by sector, human pathogens and toxins involved, number of affected persons, incident type and root causes.
METHODS METHODS
Laboratory incidents that occurred in 2018 were reported through the LINC system. The number of laboratory incidents, people exposed and laboratory-acquired infections were compared to previous years, then the incidents were analyzed by sector, human pathogen or toxin involved, the type of incident, people exposed, route of exposure and root causes. Microsoft Excel 2016 was used for descriptive analysis.
RESULTS RESULTS
In 2018, there were 89 exposure incidents to human pathogens and 235 people were exposed. There were five suspected and one confirmed laboratory-acquired infections. This was approximately twice the number of exposure incidents that were reported in 2017 (n=44) and 2016 (n=46). The highest number of exposure incidents occurred in the academic and hospital sectors, and the ratio of incidence to licences was the lowest in the private sector. The majority of incidents (n=50; 56%) involved Risk Group 2 human pathogens that were manipulated in a Containment Level 2 laboratory. Most exposures were related to sharps or procedures and the most common people exposed were laboratory technicians. Human interaction and standard operating procedures were the leading root causes.
CONCLUSION CONCLUSIONS
Although overall the annual incidence of laboratory exposures in Canada remains relatively low, the incidence was higher in 2018 than in previous years. Whether this is a true increase in incidence or an increase in reporting is not known at this time as baseline estimates are still being established.

Identifiants

pubmed: 31650987
doi: 10.14745/ccdr.v45i09a04
pii: 450904
pmc: PMC6781952
doi:

Types de publication

Journal Article

Langues

eng

Pagination

244-251

Déclaration de conflit d'intérêts

Conflict of interest: None.

Références

Diagn Microbiol Infect Dis. 2008 Mar;60(3):241-6
pubmed: 17997259
Trop Med Infect Dis. 2018 Mar 26;3(2):null
pubmed: 30274433
Can Commun Dis Rep. 2017 Nov 02;43(11):228-235
pubmed: 29770052
J Clin Microbiol. 2013 Sep;51(9):3055-62
pubmed: 23824774
Annu Rev Microbiol. 1979;33:41-66
pubmed: 386929
Clin Microbiol Rev. 1995 Jul;8(3):389-405
pubmed: 7553572
Can Commun Dis Rep. 2018 Nov 01;44(11):297-304
pubmed: 30996692
Front Bioeng Biotechnol. 2015 Apr 28;3:56
pubmed: 25973418
Science. 2013 Mar 1;339(6123):1036-7
pubmed: 23429700

Auteurs

D Choucrallah (D)

Public Health Agency of Canada, Centre for Biosecurity, Ottawa, ON.

L Sarmiento (L)

Public Health Agency of Canada, Centre for Biosecurity, Ottawa, ON.

S Ettles (S)

Public Health Agency of Canada, Centre for Biosecurity, Ottawa, ON.

F Tanguay (F)

Public Health Agency of Canada, Centre for Biosecurity, Ottawa, ON.

M Heisz (M)

Public Health Agency of Canada, Centre for Biosecurity, Ottawa, ON.

E Falardeau (E)

Public Health Agency of Canada, Centre for Biosecurity, Ottawa, ON.

Classifications MeSH